Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...
The US equity market stands at the most extreme valuations in history, on the measures we find best correlated with actual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results